In the press

January 31, 2024

Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science

Partnership represents firm’s second international collaboration and provides access to groundbreaking research taking place within world’s fifth largest pharmaceutical market

The following excerpt was taken from GlobeNewswire – continue reading here.

CINCINNATI, January 31, 2023 (GLOBE NEWSWIRE) – Orange Grove Bio, a drug investment and development firm, today announced that it has established a new strategic collaboration with Bina, the translational research and innovation unit of the Weizmann Institute of Science, designed to tap into and strengthen the rapidly expanding biotechnology entrepreneurial ecosystem in the Middle East. Located in Rehovot, Israel, just south of Tel Aviv, the Weizmann Institute of Science is one of the world’s leading basic research institutions, consisting of 280 experimental and theoretical research groups across multiple faculties including biology, biochemistry, and chemistry, among others. With a reputation for scientific rigor and innovation, the institute and its researchers are credited with undertaking foundational research that supported the development of several key therapeutics including Gleevec®, Copaxone®, Rebif® and Erbitux®.

Orange Grove’s agreement with the Weizmann Institute of Science includes a formal memorandum of understanding with its academic innovation hub, known as Bina (Bridge, Innovate, Nurture, Advance). Bina is focused on identifying, nurturing and supporting early-stage basic research projects which are likely to produce intellectual property with practical applications. Through its collaboration with Bina, Orange Grove will guide and mentor cutting-edge early-stage research taking place across the Weizmann Institute of Science.

As part of the collaboration, Orange Grove Bio and Bina will scout for translation of scientific discoveries made by researchers across the Weizmann Institute of Science. Orange Grove Bio will work collaboratively with Bina to identify and foster opportunities to create proof-of-concept in the field of drug development across a broad range of therapeutic areas. This will include spearheading educational programming and mentoring sessions for scientific staff, including faculty and students, as well as implementation of a graduate internship program that provides guidance and real-world biotech industry experience.

Related Press